Piflufolastat Approved as Diagnostic Tool for Adults with Prostate Cancer
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the medicine piflufolastat (18F)...
What do you think?
Log in to reply to this SHMOOZ post.
There are no replies yet.